par Burny, Wivine ;Marchant, Arnaud ;Hervé, Caroline;Callegaro, Andrea;Caubet, Magalie;Fissette, Laurence;Gheyle, Lien;Legrand, Catherine;Ndour, Cheikh;Tavares Da Silva, Fernanda;van der Most, Robbert;Willems, Fabienne ;Didierlaurent, Arnaud M;Yarzabal, Juan;ECR-008 study group,
Référence Vaccine
Publication Publié, 2019-03
Référence Vaccine
Publication Publié, 2019-03
Article révisé par les pairs
Résumé : | Adjuvants like AS01B increase the immunogenicity of vaccines and generally cause increased transient reactogenicity compared with Alum. A phase II randomized trial was conducted to characterize the response to AS01B and Alum adjuvanted vaccines. A post-hoc analysis was performed to examine the associations between reactogenicity and innate immune parameters. |